Multiple Sclerosis/Parkinsons Flashcards
signs of MS?
weakness or numbness, monocular visual loss, diplopia, vertigo, facial weakness, sphncter disturbances, ataxia, nystagmus, heat sensitivity
what is Relapsing remitting MS
episodes resolve with good neuro function tween exacerbations and minimal to no cumulative deficits (can move into secondary progressive MS)
what is primary progressive MS?
episodes do not fully resolve, cumulative defects.
Age range commonly affected?
20-40 years old.
Risk factors for MS?
family hx, neorthern european, women, viral infections, autoimmune dx
diangose?
MRi
lumber puncture - rule out infections, see pleocytosis, pred monocytes, increase total protein, high immog G, oligoclonal bodies, increase myelin basic protein
potential testing -
Tx MS?
exacerbation: systemic high dose corticosteroids
immunotherapy - intereron Beta1b (betaseron extavia); interferon beta 1a (avonex, rebif)
immunosupp - mitoxantrone
monocolonal antibody - natalizumab
subQ glatiramer acetate (copaxone) - block demylenation
fingolimod - traps immune cells in lymph nodes (monitor HR)
teriglunomide - inhibits production of T and B cells (monitor liver cells)
What SE should be watched for monocolonal anitbody natalizumab?
progressive multifocal leukoencephalopathy.
Parkinsons age at onset?
60+
what are 6 cardinal features?
tremor at rest, rigidity, bradykinesia, flexed posture, loss postural reflexes, masklike facies
other:
little movement of hands/arms during ambulation, forward falls
TX parkinsons?
1) dopamine agonists: ropinirole (requip), pramipexole (mirapex)
apomorphine - injectinle for rescue for off periods.
2) levodopa - can be given with carbidopa via sinemet.
3) amantadine (symmetrel) - antiviral drug to reduce dyskinesia
4) cOMT inhibitors - tolcapone (tasmar), entacapone (comtan), increase half ive of levodopa
5) MAO B inhibitor - selegeline, rasalgilin - reduce metabolism of levodopa to increase half life
6) anticholintergics - benzotropine (congentin). help with tremor
7) pallidotomy
8) deep brain stimulation
how do dopamine agonists tx parkinons
neuroprotective effect